Irvine Pharmaceutical Services, Inc., has announced the forthcoming January 2009 launch of Avrio Biopharmaceuticals. This venture is part of Irvine’s overall growth strategy focused on improving its services and product offerings to current and potential clients. Outfitted with an experienced team and state of the art equipment, Avrio Biopharma will provide a full range of formulation development and aseptic fill-and-finish services. It will be focused on developing optimized production processes and providing dependable filling, lyophilization and packaging capabilities for early phase clinical trial materials. “We are very excited about this extension of our company,” said Assad J. Kazeminy, CEO and Founder of Irvine Pharmaceutical Services. “Avrio will help round out our existing capabilities and its connection to Irvine will also make it possible to provide our clients with broader services via seamless partnership.” Since early 2007, Irvine Pharmaceutical Services, Inc., has experienced extensive growth and has made significant upgrades in its lab equipment and infrastructure. The opening of Avrio Biopharma is yet another step along the same growth lines, striving to better serve the needs of the company’s clients and the pharmaceutical industry.